173 related articles for article (PubMed ID: 26032093)
1. Expressions of miR-181a and miR-20a in RPMI8226 cell line and their potential as biomarkers for multiple myeloma.
Peng J; Thakur A; Zhang S; Dong Y; Wang X; Yuan R; Zhang K; Guo X
Tumour Biol; 2015 Nov; 36(11):8545-52. PubMed ID: 26032093
[TBL] [Abstract][Full Text] [Related]
2. MiR-19b and miR-20a suppress apoptosis, promote proliferation and induce tumorigenicity of multiple myeloma cells by targeting PTEN.
Yuan J; Su Z; Gu W; Shen X; Zhao Q; Shi L; Jin C; Wang X; Cong H; Ju S
Cancer Biomark; 2019; 24(3):279-289. PubMed ID: 30883341
[TBL] [Abstract][Full Text] [Related]
3. miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation.
Wang M; Gu H; Qian H; Zhu W; Zhao C; Zhang X; Tao Y; Zhang L; Xu W
Eur J Cancer; 2013 May; 49(8):2010-21. PubMed ID: 23333058
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer.
Yang T; Thakur A; Chen T; Yang L; Lei G; Liang Y; Zhang S; Ren H; Chen M
Tumour Biol; 2015 Jun; 36(6):4357-65. PubMed ID: 25874488
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
Xu H; Zhu J; Hu C; Song H; Li Y
J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Sprouty homologĀ 2 by microRNA-21 inhibits proliferation, metastasis and invasion, however promotes the apoptosis of multiple myeloma cells.
Wang JH; Zhou WW; Cheng ST; Liu BX; Liu FR; Song JQ
Mol Med Rep; 2015 Aug; 12(2):1810-6. PubMed ID: 25825239
[TBL] [Abstract][Full Text] [Related]
8. [Effect of miR-202 on the growth of multiple myeloma cells via regulating B cell-activating factor and the underlying mechanism].
Yu JJ; Shen XJ; Wang XD; Ju SQ
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):886-91. PubMed ID: 24506956
[TBL] [Abstract][Full Text] [Related]
9. Interaction between microRNA-181a and TNFAIP1 regulates pancreatic cancer proliferation and migration.
Zhang P; Guo Z; Hu R; He X; Jiao X; Zhu X
Tumour Biol; 2015 Dec; 36(12):9693-701. PubMed ID: 26152285
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression.
Mao W; Huang X; Wang L; Zhang Z; Liu M; Li Y; Luo M; Yao X; Fan J; Geng J
J Exp Clin Cancer Res; 2019 Apr; 38(1):169. PubMed ID: 30999937
[TBL] [Abstract][Full Text] [Related]
11. Study on the Association Between miRNA-202 Expression and Drug Sensitivity in Multiple Myeloma Cells.
Shen X; Guo Y; Qi J; Shi W; Wu X; Ni H; Ju S
Pathol Oncol Res; 2016 Jul; 22(3):531-9. PubMed ID: 26689580
[TBL] [Abstract][Full Text] [Related]
12. MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.
Shi Q; Zhou Z; Ye N; Chen Q; Zheng X; Fang M
Cancer Biomark; 2017 Dec; 20(4):539-546. PubMed ID: 28946554
[TBL] [Abstract][Full Text] [Related]
13. miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma.
Zhao X; Zhang W; Ji W
Future Oncol; 2018 Jul; 14(17):1741-1753. PubMed ID: 29517349
[TBL] [Abstract][Full Text] [Related]
14. Long Non-Coding RNA MEG3 Functions as a Competing Endogenous RNA to Regulate HOXA11 Expression by Sponging miR-181a in Multiple Myeloma.
Shen X; Bai H; Zhu H; Yan Q; Yang Y; Yu W; Shi Q; Wang J; Li J; Chen L
Cell Physiol Biochem; 2018; 49(1):87-100. PubMed ID: 30134227
[TBL] [Abstract][Full Text] [Related]
15. Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells.
Guo J; Zhao Y; Fei C; Zhao S; Zheng Q; Su J; Wu D; Li X; Chang C
Cell Death Dis; 2018 May; 9(5):512. PubMed ID: 29724992
[TBL] [Abstract][Full Text] [Related]
16. MiR-301a promotes cell proliferation by directly targeting TIMP2 in multiple myeloma.
Liang B; Yin JJ; Zhan XR
Int J Clin Exp Pathol; 2015; 8(8):9168-74. PubMed ID: 26464662
[TBL] [Abstract][Full Text] [Related]
17. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
[TBL] [Abstract][Full Text] [Related]
18. MiR-181a promotes growth of thyroid cancer cells by targeting tumor suppressor RB1.
Le F; Luo P; Yang QO; Zhong XM
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5638-5647. PubMed ID: 29271997
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
Pichiorri F; Suh SS; Ladetto M; Kuehl M; Palumbo T; Drandi D; Taccioli C; Zanesi N; Alder H; Hagan JP; Munker R; Volinia S; Boccadoro M; Garzon R; Palumbo A; Aqeilan RI; Croce CM
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12885-90. PubMed ID: 18728182
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis.
Zou C; Chen J; Chen K; Wang S; Cao Y; Zhang J; Sheng Y; Huang A; Tang H
Exp Cell Res; 2015 Feb; 331(2):352-61. PubMed ID: 25449696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]